ALEXANDRIA, Va., July 16 -- United States Patent no. 12,667,541, issued on June 30, was assigned to AstraZeneca AB (Sodertalje, Sweden).
"Dry powder formulation for pulmonary delivery and methods of use" was invented by Laura Forster (Bad Homburg vor der Hohe, Germany), Mats Hertel (Bad Homburg vor der Hohe, Germany) and Christoph Gremmel (Bad Homburg vor der Hohe, Germany).
According to the abstract* released by the U.S. Patent & Trademark Office: "Pharmaceutical compositions are provided for pulmonary administration of a JAK inhibitor, and, for example, dry powder formulations that include a JAK inhibitor and an agglomerated lactose carrier. Methods of making and using the pharmaceutical composition, as well as kits and dosage forms are...